wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45070718-20DCD4A6-D138-40B0-84DC-E9F216D41079
Q45070718-20DCD4A6-D138-40B0-84DC-E9F216D41079
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45070718-20DCD4A6-D138-40B0-84DC-E9F216D41079
Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review.
P2860
Q45070718-20DCD4A6-D138-40B0-84DC-E9F216D41079
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45070718-20DCD4A6-D138-40B0-84DC-E9F216D41079
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b33e27999e14ef461aade8480cd6cb473a58676
P2860
FDA Approval Summary: Rucaparib for the treatment of patients with deleterious BRCA mutation-associated advanced ovarian cancer.